Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
Early P 1 (1)
P 1 (1)
P 3 (1)

Trial Status

Completed6
Not Yet Recruiting2
Terminated2
Recruiting2
Unknown2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (14)

Research Network

Activity Timeline